SPINEWAY Inactive Instrument
SPINEWAY Share Price Swiss Exchange
Equities
FR0011398874
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 04-17 | Spineway: punished despite a solid first quarter | CF |
| 04-16 | Spineway SA Announces Revenue Results for the First Quarter of 2024 | CI |
| Sales 2022 | 8.53M 9.21M 722M | Sales 2023 | 11.36M 12.27M 962M | Capitalization | 550K 594K 46.57M |
|---|---|---|---|---|---|
| Net income 2022 | -3M -3.24M -254M | Net income 2023 | -6M -6.48M -508M | EV / Sales 2022 | - |
| Net cash position 2022 | 4.08M 4.41M 346M | Net Debt 2023 | 814K 879K 68.93M | EV / Sales 2023 | - |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
-
| Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 2.55% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Stéphane Le Roux
CEO | Chief Executive Officer | 63 | 27/09/05 |
| Director of Finance/CFO | - | 26/01/20 | |
Sandrine Carle
PRN | Corporate Officer/Principal | - | 11-06 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Weiguang Guo
BRD | Director/Board Member | 68 | - |
Stéphane Le Roux
CEO | Chief Executive Officer | 63 | 27/09/05 |
Joseph Brigneaud
BRD | Director/Board Member | 46 | 12/10/17 |
Spineway designs, produces, and sells spinal column implants and surgical instruments. The group offers spinal systems, cervical and lumbar cages, cervical plates, bone substitutes, etc.
Net sales are distributed geographically as follows: France (27.8%), Europe (21.4%), Latin America (29.8%), Asia (16.1%) and the Middle East and Africa (4.9%).
Calendar
16/07/2024
- Q2 2024 Sales and Revenue Release
| 1st Jan change | Capi. | |
|---|---|---|
| -7.03% | 178B | |
| -6.32% | 98.95B | |
| -6.15% | 66.14B | |
| -10.62% | 44.11B | |
| +8.34% | 43.82B | |
| +11.91% | 42.07B | |
| +11.64% | 28.92B | |
| +17.68% | 24.69B | |
| -8.87% | 23.38B |
